{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:11:35Z","timestamp":1791976295059,"version":"4.4.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ijpharm.2004.09.022","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T00:16:50Z","timestamp":1104365810000},"page":"189-195","source":"Crossref","is-referenced-by-count":85,"title":["Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles"],"prefix":"10.1016","volume":"289","author":[{"given":"Tanima","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2004.09.022_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0378-5173(02)00267-3","article-title":"Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles","volume":"243","author":"Banerjee","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(97)00136-3","article-title":"Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates","volume":"50","author":"Bernkop-Schnurch","year":"1998","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0270(01)00450-2","article-title":"PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases","volume":"111","author":"Calvo","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ijpharm.2004.09.022_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5173(86)90021-9","article-title":"Biodistribution of poly (butyl 2 cyanoacrylate) nanoparticles in rabbits","volume":"34","author":"Douglas","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00447-0","article-title":"Biodistribution of fluoresceinated dex-tran using novel nanoparticles evading reticuloendothelial system","volume":"202","author":"Gaur","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib6","series-title":"Chemistry of Pharmaceuticals. Radiopharmaceuticals in Nuclear Medicine Practice, USA","year":"1987"},{"key":"10.1016\/j.ijpharm.2004.09.022_bib7","first-page":"283","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib8","series-title":"Textbook of Radiopharmacy: Theory and Practice","first-page":"58","article-title":"Physico-chemical concepts in the preparation of Technetium radiopharmaceuticals","author":"Nowotnik","year":"1990"},{"key":"10.1016\/j.ijpharm.2004.09.022_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(99)00063-2","article-title":"Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting","volume":"60","author":"Peracchia","year":"1999","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0169-409X(95)00025-3","article-title":"Long circulating microparticulate drug carriers","volume":"16","author":"Stolnik","year":"1995","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ijpharm.2004.09.022_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0169-409X(95)00039-A","article-title":"Surface modification of nanoparticles to oppose uptake by mononuclear phagocyte system","volume":"17","author":"Storm","year":"1995","journal-title":"Adv. Drug Del. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304005708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304005708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:22:23Z","timestamp":1548858143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304005708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0378517304005708"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2004.09.022","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}